Brief: Emyria Says Emyria Receives Ethics Approval For Emd-Rx5 Phase 3 Trial
16/08/2022 02:30
Aug 16 (Reuters) - Emyria EMD.AX :
* EMYRIA RECEIVES ETHICS APPROVAL FOR EMD-RX5 PHASE 3
TRIAL-EMD.AX
Source text for Eikon: ID:nASX3fqj10
Further company coverage: EMD.AX
((Reuters.Briefs@thomsonreuters.com;))